Catalyst Wire Dossier Catalyst Wire Dossier

Lobaplatin/etoposide with or without anlotinib maintenance

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lobaplatin/etoposide with or without anlotinib maintenance, covering 2019-11-29 to 2019-11-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC [Phase 2]

See pricing